Neuraly

glial activation inhibition, GLP-1R agonism, neuroinflammation

modulatingsmall molecule

neuralymed.com·Washington DC, District of Columbia, United States·Acquired

01Overview 02People 03Projects 04Concepts 05Patents 06Public records 07Belief evolution

Plate C · C-PPW7

Belief evolution

company mission2018-07-22

Neuraly states that its purpose is to translate breakthrough scientific discoveries into revolutionary treatments for patients with neurodegenerative diseases, with its science and product navigation indicating a focus on neuroinflammation and diseases including Alzheimer's disease and Parkinson's disease.

Source

company mission for neurodegenerative disease treatment2019-01-02

Neuraly stated that it aimed to translate breakthrough scientific discoveries into revolutionary treatments for patients with neurodegenerative diseases, indicating a belief that its science can be turned into impactful therapies for these conditions.

Source

mission to develop treatments for neurodegenerative diseases, with a stated focus on neuroinflammation2020-01-22

Neuraly presents itself as a company focused on turning breakthrough scientific discoveries into revolutionary treatments for patients with neurodegenerative diseases. The visible site structure also indicates that it organizes its scientific approach around neuroinflammation, suggesting this as a core area of belief or therapeutic focus.

Source

Loading

Loading section...

0-100 chain-logic scale · 15 dimensions · scored on public evidence